Other articles of interest

Repetitive ambulatory levosimendan as a bridge to heart transplantation

Javier de Juan Bagudá, Fernando de Frutos, Raquel López-Vilella, David Couto Mallón, Joan Guzman-Bofarull, Zorba Blazquez-Bermejo, Manuel Cobo-Belaustegui, Cristina Mitroi, Francisco J. Pastor-Pérez, Carlos Moliner-Abós, Diego Rangel-Sousa, Beatriz Díaz-Molina, Javier Tobar-Ruiz, Nahikari Salterain Gonzalez, José Manuel García-Pinilla, María Dolores García-Cosío Carmena, María Generosa Crespo-Leiro, David Dobarro, Luis Almenar, Juan F. Delgado-Jiménez, Emilio Paredes-Galán, Francisco González-Vílchez, José González-Costello,

Rev Esp Cardiol. 2024;77:290-301
Prevalence of transthyretin cardiac amyloidosis in patients with heart failure with preserved ejection fraction: the PRACTICA study

Pablo García-Pavía, José Manuel García-Pinilla, Ainara Lozano-Bahamonde, Sergi Yun, Antonio García-Quintana, Juan José Gavira-Gómez, Miguel Ángel Aibar-Arregui, Gonzalo Barge-Caballero, Julio Núñez Villota, Laura Bernal, Patricia Tarilonte,

Rev Esp Cardiol. 2025;78:301-10
NT-proBNP in systemic right ventricles: a new cutoff level for risk stratification?

Fabian Tran, Francisco Javier Ruperti-Repilado, Philip Haaf, Pedro Lopez-Ayala, Matthias Greutmann, Markus Schwerzmann, Judith Bouchardy, Harald Gabriel, Dominik Stambach, Juerg Schwitter, Kerstin Wustmann, Michael Freese, Christian Mueller, Daniel Tobler,

Rev Esp Cardiol. 2025;78:107-16